Market Place
Sourcing Support
Psilera Partners with Hesperos to advance PSIL-006 for Dementia
09 Jun 2025 //
PR NEWSWIRE
Psilera & Atai Sign Licensing Agreement For DMT Patent Portfolio
20 Feb 2025 //
PR NEWSWIRE
Psilera Welcomes Biopharma Executive Dr. Magali Haas to its Board of Directors
26 Mar 2024 //
PR NEWSWIRE
Psilera Announces Lead Indication for PSIL-006
23 Jan 2024 //
PR NEWSWIRE
Psilera Unveils Psilocybin Derivative PSIL-006 As Lead Candidate
25 May 2023 //
PR NEWSWIRE
Psilera to Unveil Lead Clinical Compound at Live-Streamed Event on May 25, 2023
09 May 2023 //
PR NEWSWIRE
Psilera to Present on International Stage at Biotech Showcase in San Francisco
08 Dec 2022 //
PRNEWSWIRE
Psilera Receives First Patent Allowance for Transdermal Patch Formulations
14 Sep 2022 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.